Gil Kaminski is a product management and clinical operations leader, with over 15 years of experience in healthcare Artificial Intelligence / Machine Learning (AI/ML). She is the co-founder of Humelan, a Public Benefit Corporation committed to helping individuals navigate the complexities of hearing health and wellness. Through its person-centered approach, community support, and an AI companion app, Humelan provides a comprehensive solution to those experiencing hearing loss.
Her career is rooted in technology R&D and clinical operations, having contributed to various healthcare and medtech organizations including Laguna Health, DaVita Kidney Care, WideMed Ltd, and the Israel Defense Force (IDF)’s Naval Medical Institute.
Gil holds an MBA from the Wharton School and a BS in Biomedical Engineering from the Technion - Israel Institute of Technology.
Contact Gil at: [email protected] | LinkedIn
Erez Kaminski is the CEO and Founder of Ketryx Corporation, the first and only connected lifecycle management software for MedTech that unifies quality and R&D efforts to deliver safer software. Over the last decade, he worked in industries including computational mathematics, biotech, and energy, helping build monitoring systems for pharmaceutical equipment and AI for medication management.
Before Ketryx, Erez worked with Amgen, the world’s largest biotechnology company, as the head of AI/ML for their medical device division and with Wolfram Research, the builders of Mathematica and Wolfram|Alpha. Erez holds a Master of Science in Electrical Engineering and Computer Science and a Master of Business Administration from the Massachusetts Institute of Technology.
Contact Erez at: LinkedIn